盈建科 reported revenue of ¥0.05B for the period ended 2026-06-30, -4.9% year on year. Net income was ¥-0.04B, a -85.4% net margin on a 88.8% gross margin. The largest revenue line is 软件销售 at 55% of the total. Free cash flow for the period was ¥-0.02B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.05B | -4.9% |
| Gross profit | ¥0.04B | — |
| Operating income | ¥-0.04B | — |
| Net income | ¥-0.04B | — |
| Gross margin | 88.8% | Net margin -85.4% |
| Revenue Q/Q | +179.9% | — |
| Segment | Revenue | Share |
|---|---|---|
| 软件销售 | ¥0.03B | 54.8% |
| 技术开发和服务 | ¥0.01B | 30.1% |
| 软件使用费 | ¥0.00B | 10.5% |
| 其他(补充) | ¥0.00B | 4.6% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.01B | 11.2% |
| R&D | ¥0.04B | 82.3% |
| SG&A | ¥0.05B | 105.9% |
| Tax & other | ¥-0.00B | -0.4% |
| Item | Amount |
|---|---|
| Total assets | ¥0.76B |
| Total liabilities | ¥0.04B |
| Shareholders' equity | ¥0.72B |
| Equity / assets | 94.8% |
| Operating cash flow | ¥-0.02B |
| Capital expenditure | ¥0.00B |
| Free cash flow | ¥-0.02B |
| Cash conversion (OCF / net income) | 149% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
中英科技 ・ 药易购 ・ 信测标准 ・ 秋田微 ・ 南极光 ・ 创识科技 ・ 易瑞生物 ・ 春晖智控 ・ 曼卡龙 ・ 恒而达 ・ 德必集团 ・ 冠中生态
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies